The molecular aetiology of central obesity: moving from variant to function using large-scale data-driven approaches. (360G-Wellcome-221782_Z_20_Z)
Central obesity is a leading contributing cause of illness and death across the world. Currently available strategies for prevention and treatment of this condition are manifestly inadequate. The research proposed here aims to identify fundamental processes involved in the development of central obesity. I plan to harness the power of human genetics, fused with deep molecular characterisation of the adipocytes to generate novel insights into the biology of central obesity. This ‘multi-omics’ approach will provide the basis for more effective preventative and therapeutic approaches that reduce the burden of central obesity and associated disease.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | South East |
| Award Date | 2020-12-01T00:00:00+00:00 |
| Internal ID | 221782/Z/20/Z |
| Planned Dates: End Date | 2027-06-30T00:00:00+00:00 |
| Planned Dates: Start Date | 2021-07-01T00:00:00+00:00 |
| Amount Awarded | 2059266 |
| Financial Year | 2020/21 |
| Lead Applicant | Dr Duncan Stuart Sinclair Palmer |
| Grant Programme: Title | Residual Award |
| Applicant Surname | Palmer |
| Approval Committee | Science Interview Panel |
| Recipient Org: Country | United Kingdom |
| Recipient Org: City | Oxford |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | No |
| Total amount including partnership funding | 2059266 |